Clinical trials
Hyperlipidemias trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2013 | 5 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| Chinese University of Hong Kong | 3 |
| Novartis Pharmaceuticals | 3 |
| The University of Hong Kong | 2 |
| Pfizer | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 14 |
| Hypercholesterolemia | 7 |
| Dyslipidemias | 3 |
| Hypertension | 3 |
| Cardiovascular Diseases | 2 |
| Coronary Artery Disease | 2 |
| Coronary Stenosis | 2 |
| Acute Coronary Syndrome | 1 |
| Aortic Valve Stenosis | 1 |
| Heart Failure | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.